510(k) Report

510(k) · Cleared

Cleared

Capstone R Spinal System

K103731510(k) TraditionalCleared Jul 18, 2011208-day reviewClass II21 CFR 888.3080

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medtronic Sofamor Danek · MAX Intervertebral Fusion Device With Bone Graft, Lumbar

Cleared on Jul 18, 2011 after a 208-day review. The FDA summary names its predicate without a number. 1 of the 908 devices in its family, counting itself, has a Class I recall. 907 later devices descend from it.

Decided
Jul 18, 2011
Review
208 days
Class
Class II
Product code
MAX
Recalls
None
Predicates
0

907 later devices descend from it, 6 citing it directly. 1 of the 908 devices in this family, counting this one, has a Class I recall.

Descendants, by year cleared 2013: 6 descendants cleared2012: 4 descendants cleared2020: 83 descendants cleared2015: 14 descendants cleared2016: 33 descendants cleared2018: 57 descendants cleared2014: 13 descendants cleared2017: 47 descendants cleared2019: 75 descendants cleared2021: 83 descendants cleared, 1 with a Class I recall12022: 90 descendants cleared2025: 93 descendants cleared2026: 77 descendants cleared2024: 114 descendants cleared2023: 118 descendants cleared2010201520202025
  1. This deviceK103731 Capstone R Spinal SystemMedtronic Sofamor Danek · 2011
  2. Descendant · cites it directly · 761 of its ownK120368 Capstone Control Spinal SystemMedtronic Sofamor Danek USA, Inc. · 2012
  3. Descendant · cites it directly · 723 of its ownK121760 Capstone Spinal SystemMedtronic Sofamor Danek USA, Inc. · 2012
  4. Descendant · cites it directly · 709 of its ownK123027 Capstone (R) Spinal SystemMedtronic Sofamor Danek, Inc. · 2013
  5. Descendant · 2 generations on · 480 of its ownK141896 Coroent SystemNu Vasive, Incorporated · 2014
  6. Descendant · 3 generations on · 479 of its ownK151472 NuVasive CoRoent Lumbar SystemNu Vasive, Incorporated · 2015

Showing 5 of 907 descendants. See all descendants

Descendants cleared per year

2012: 42013: 62014: 132015: 142016: 332017: 472018: 572019: 752020: 832021: 832022: 902023: 1182024: 1142025: 932026: 77
2012high 118 (2023) · low 4 (2012)2026

Class I recalls in this family

Most influential descendants

Showing 5 of 907 · See all
  • K120368Capstone Control Spinal SystemMedtronic Sofamor Danek USA, Inc. · 2012 · cites it directly761descendants
  • K121760Capstone Spinal SystemMedtronic Sofamor Danek USA, Inc. · 2012 · cites it directly723descendants
  • K123027Capstone (R) Spinal SystemMedtronic Sofamor Danek, Inc. · 2013 · cites it directly709descendants
  • K141896Coroent SystemNu Vasive, Incorporated · 2014 · 2 generations on480descendants
  • K151472NuVasive CoRoent Lumbar SystemNu Vasive, Incorporated · 2015 · 3 generations on479descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K103731Capstone R Spinal SystemMedtronic Sofamor Danek2011—
+1K120368Capstone Control Spinal SystemMedtronic Sofamor Danek USA, Inc.2012—
+1K121760Capstone Spinal SystemMedtronic Sofamor Danek USA, Inc.2012—
+1K123027Capstone (R) Spinal SystemMedtronic Sofamor Danek, Inc.2013—
+2K141896Coroent SystemNu Vasive, Incorporated2014—
+3K151472NuVasive CoRoent Lumbar SystemNu Vasive, Incorporated2015—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201240
201360
2014130
2015140
2016330
2017470
2018570
2019750
2020830
2021831
2022900
20231180
20241140
2025930
2026770
FIG. 1 — Lineage of K103731, 2011–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MAX device

  1. #1 K203714 NuVasive Thoracolumbar Interbody Systems…score 102.5 · 24 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—CAPSTONE® Spinal System
Named without a submission number
—

What descends from it? (907)

See all 907

6 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K120368Capstone Control Spinal SystemMedtronic Sofamor Danek USA, Inc.2012761
K121760Capstone Spinal SystemMedtronic Sofamor Danek USA, Inc.2012723
K123027Capstone (R) Spinal SystemMedtronic Sofamor Danek, Inc.2013709
K113642Perimeter Interbody Fusion DeviceMedtronic Sofamor Danek USA2012292
K131425Navigated Capstone Trials, Clydesdale Trials, Capstone & Clydesdale InserterMedtronic Navigation, Inc.2013246
K192502Anatomic PEEK™ Cervical Fusion System, Anatomic PEEK™ PTC Cervical Fusion System…Medtronic Sofamor Danek USA, Inc.20204

Has anything in its family been recalled? (1 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K211616ExcelsiusHubGlobus Medical, Inc. · 2021 · 4 generations on · ◆ in the 2021 descendants bar of FIG. 11 Class I recall

What does this lineage say?

  • Of its descendants, K120368 (Medtronic Sofamor Danek USA, Inc., 2012) has gone furthest, with 761 descendants of its own.

How does its category compare?

All MAX devices

MAX Intervertebral Fusion Device With Bone Graft, Lumbar: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · MAX

29in 2025

2007: 72008: 352009: 312010: 292011: 492012: 482013: 582014: 582015: 532016: 642017: 762018: 642019: 602020: 562021: 532022: 412023: 302024: 382025: 292026 (partial year): 18
2007high 76 (2017) · low 7 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MAX

85in 2025

2007: 86 days median2008: 88 days median2009: 102 days median2010: 137 days median2011: 98 days median2012: 69 days median2013: 102 days median2014: 115 days median2015: 113 days median2016: 124 days median2017: 116 days median2018: 114 days median2019: 131 days median2020: 106 days median2021: 109 days median2022: 95 days median2023: 87 days median2024: 91 days median2025: 85 days median2026 (partial year): 95 days median
2007high 137 (2010) · low 69 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MAX

5in 2025

2008: 22009: 92011: 32012: 11, 1 Class I2014: 32015: 12016: 62017: 12018: 42019: 12022: 12024: 12025: 5
2007high 11 (2012) · low 0 (2007)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · MAX

811in 2025

2007: 122008: 192009: 902010: 1542011: 2012012: 3272013: 3802014: 3662015: 5242016: 6472017: 5962018: 6162019: 6992020: 6402021: 6222022: 6182023: 5762024: 7292025: 811
2007high 811 (2025) · low 12 (2007)2025

MAUDE reports naming product code MAX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007786012
20083588219
200931102990
2010291370154
201149983201
2012486911 (1)327
2013581020380
2014581153366
2015531131524
2016641246647
2017761161596
2018641144616
2019601311699
2020561060640
2021531090622
202241951618
202330870576
202438911729
202529855811
202618950—

What is it indicated for?

The CAPSTONE® Spinal System is indicated for use with autogenous bone graft in patients with degenerative disc disease (DDD) at one or two levels from L2 to SI1. These DDD patients may also have up to Grade I Spondylolisthesis or retrolisthesis at the involved levels. DDD is defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies. These patients should be skeletally mature and have had six months of…

Read the full statement (138 words)

The CAPSTONE® Spinal System is indicated for use with autogenous bone graft in patients with degenerative disc disease (DDD) at one or two levels from L2 to SI1. These DDD patients may also have up to Grade I Spondylolisthesis or retrolisthesis at the involved levels. DDD is defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies. These patients should be skeletally mature and have had six months of non-operative treatment. These implants may be implanted via an open or a minimally invasive posterior approach. Alternatively, these implants may also be implanted via an anterior and/or transforaminal approach. These implants are to be used with autogenous bone graft. These devices are intended to be used with supplemental fixation instrumentation, which has been cleared by the FDA for use in the lumbar spine.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K103731: Capstone R Spinal System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K103731

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026